不孕症试验中妊娠结局定义的存在性、清晰性和一致性:一项系统综述
该系统综述纳入2012年至2023年发表的1425项不孕症随机对照试验,评估生化妊娠、临床妊娠、持续妊娠和活产的报告率及定义。仅34.0%报告活产,12.2%同时报告临床妊娠、持续妊娠和活产;定义缺失、模糊或异质常见,活产定义仅41.1%提供。
要点
- 1425项不孕症随机对照试验中仅34.0%报告活产,12.2%同时报告三种妊娠结局。
- 活产定义提供率最低(41.1%),临床妊娠定义中仅63.4%明确确认时机。
- 报告活产的试验比例从2012年23.1%上升至2023年33.7%。
核心结论
- 过去十年仅三分之一的不孕症随机对照试验报告活产,与长期推荐存在脱节。
- 妊娠结局定义显著缺乏且变异大,需增加标准化妊娠结局的传播和采用。
- 报告活产的试验比例呈持续上升趋势。
研究设计与样本
- 系统检索Embase、Medline和CENTRAL从2012年1月至2023年8月的不孕症随机对照试验。
- 纳入涉及不孕女性的随机对照试验,排除二次分析、中期分析和会议摘要。
- 共纳入1425项随机对照试验,两名作者独立筛选文献。
- 使用R语言文本挖掘提取妊娠定义和试验特征,辅以人工核查。
- 随机抽取50篇文章验证提取数据准确性,灵敏度和特异度均≥90%。
主要发现
- 419项(29.4%)报告生化妊娠,1359项(95.4%)报告临床妊娠,404项(28.4%)报告持续妊娠,484项(34.0%)报告活产,仅174项(12.2%)同时报告临床妊娠、持续妊娠和活产。
- 报告活产的试验比例从2012年23.1%上升至2023年33.7%。
- 报告至多生化妊娠或临床妊娠的试验更可能未注册、样本量更小、单中心、发表于非第一四分位期刊。
- 生化妊娠、临床妊娠、持续妊娠和活产的定义提供率分别为68.5%(287/419)、64.5%(876/1359)、70.5%(285/404)和41.1%(199/484)。
- 876个临床妊娠定义中63.4%(555个)明确妊娠确认时机;220个报告孕周的定义中孕周范围4至16周,最常见切点为6周(48.2%,106个)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 因需提取大量数据,使用文本挖掘辅以人工提取;随机核查研究中不足10%遗漏定义,为本研究局限。
- 仅描述已发表随机对照试验的定义模式,结果不能外推至未发表随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How frequently do infertility trials report live birth and pregnancy, and how consistently were their definitions reported? SUMMARY ANSWER: One-third of 1425 infertility trials published in the last decade reported live birth, with one in eight reporting clinical pregnancy, ongoing pregnancy, and live birth concurrently; absent, ambiguous, or heterogeneous definitions were common. WHAT IS KNOWN ALREADY: Absent or inconsistent outcome definitions in randomized controlled trials (RCTs) limit their interpretation and complicate subsequent evidence synthesis. While reporting live birth in infertility trials has been a long-running recommendation, the extent to which this is adhered to, and the temporal trend of adherence, is unclear. Furthermore, it is unknown if outcome reporting in infertility trials is clear and consistent. STUDY DESIGN, SIZE, DURATION: We studied all RCTs in infertility published between 2012 and 2023. We aimed to assess (i) whether biochemical pregnancy, clinical pregnancy, ongoing pregnancy, and live birth were reported; the temporal trends in reporting these pregnancy outcomes, and compare the characteristics of trials reporting each type of outcome; (ii) whether and how these pregnancy outcomes were defined. PARTICIPANTS/MATERIALS, SETTING, METHODS: We systematically searched Embase, Medline, and CENTRAL for RCTs in infertility from January 2012 to August 2023. RCTs involving infertile women that reported either biochemical pregnancy, clinical pregnancy, ongoing pregnancy, or live birth were eligible. Secondary analyses, interim analyses, or conference abstracts were not eligible. Two authors independently screened articles. We extracted pregnancy definitions and trial characteristics primarily using text mining in R, a programming environment for data analysis, and supplemented by manual checking. The accuracy of extracted data was validated in a random sample of 50 articles, with sensitivity and specificity all at or above 90%. MAIN RESULTS AND THE ROLE OF CHANCE: We included 1425 infertility RCTs. Among these, 419 (29.4%) reported biochemical pregnancy. While 1359 (95.4%) RCTs reported clinical pregnancy, 404 (28.4%) reported ongoing pregnancy, and 484 (34.0%) reported live birth, only 174 (12.2%) reported all three outcomes. The proportion of trials reporting live birth increased from 23.1% in 2012 to 33.7% in 2023. Trials reporting up to biochemical pregnancy or clinical pregnancy were more likely to be unregistered, smaller, single-centered, and published in non-first quarter journals. Definitions for biochemical, clinical, ongoing pregnancy, and live birth were provided in 68.5% (287/419), 64.5% (876/1359), 70.5% (285/404), and 41.1% (199/484) of articles reporting on these outcomes. Among 876 clinical pregnancy definitions, 63.4% (n = 555) specified the pregnancy confirmation timing. Of the 220 definitions that reported gestational weeks (ranging from 4 to 16 weeks), the most common cut-off was 6 weeks, used in 48.2% (n = 106) of cases. For ongoing pregnancy definitions, 96.1% (n = 274) of the 285 definitions included gestational age in weeks (ranging from 6 to 32 weeks), with 12 weeks being the most common cut-off used in 49.1% (n = 140) of definitions. Among 199 live birth definitions, 62.3% (n = 124) used a gestational age threshold (ranging from 20 to 37 weeks), with 24 weeks being the most common cut-off, used in 28.6% (n = 57) of trials. LIMITATIONS, REASONS FOR CAUTION: Due to the vast data we needed to extract, we used text-mining supplemented by manual data extraction. While we optimized the text-mining algorithm attempting to identify all types of outcome definitions and manually curated all extracted definitions, definitions were missed in less than 10% of randomly checked studies, which is a limitation of this study. We only described definition patterns in published RCTs, and our results cannot be extrapolated to unpublished RCTs. WIDER IMPLICATIONS OF THE FINDINGS: Despite long-standing recommendations to report live birth in infertility trials, in the last decade only a third of RCTs did so. This highlights a disconnection between the advocated outcome and what researchers are reporting. We observed an encouraging trend that there has been a consistent rise in the proportion of trials reporting live birth. Furthermore, the significant lack and variability of pregnancy definitions underscore the imperative to increase the dissemination and uptake of standardized pregnancy outcomes. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for the study. Q.F. reports receiving a PhD scholarship from Merck. B.W.M. is supported by an NHMRC Investigator grant (GNT1176437). B.W.M. reports consultancy, travel support, and research funding from Merck and consultancy for Organon and Norgine. B.W.M. holds stock from ObsEva. W.T.L. is supported by an NHMRC Investigator grant (GTN2016729). W.L.L. reports receiving a PhD scholarship from the China Scholarship Council. T.D.H and S.L. are employees of Merck Healthcare KGaA, Darmstadt, Germany. R.W. is supported by an NHMRC Investigator grant (GTN2009767). The other author has no conflict of interest to declare. REGISTRATION NUMBER: CRD42024498624.
引用
- Feng Q, Li W, Li W, et al. The presence, clarity, and consistency of definitions in pregnancy outcomes in infertility trials: a systematic review. Hum Reprod. 2025. PMID: 39983754. doi:10.1093/humrep/deaf022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。